Patent
   D907760
Priority
Jan 20 2017
Filed
Jan 20 2017
Issued
Jan 12 2021
Expiry
Jan 12 2036
Assg.orig
Entity
unknown
3
20
n/a
The ornamental design of an orally ingestible tablet, substantially as shown and described.

FIG. 1 is a top front perspective view of an orally ingestible tablet;

FIG. 2 is a front view thereof, the back view being a mirror image;

FIG. 3 is a top view thereof;

FIG. 4 is bottom view thereof;

FIG. 5 is a right side view thereof; and,

FIG. 6 is a left side view thereof.

The broken lines do not form part of the claimed design.

The “REM” logo forming part of the claimed design is a trademark of Physician's Seal, LLC.

Hassan, Fred, Hassan, Daniel

Patent Priority Assignee Title
D918377, Oct 11 2017 JOHNSON & JOHNSON CONSUMER INC Tablet
D947358, Mar 19 2019 Novo Nordisk A/S Pill
ER5657,
Patent Priority Assignee Title
D430285, Apr 16 1999 MERCK & CO , INC Tablet
D433121, Apr 07 1998 Pfizer Inc Pharmaceutical tablet
D433122, Apr 07 1998 Pfizer Inc Pharmaceutical tablet
D434135, Apr 07 1998 Pfizer Inc Pharmaceutical tablet
D434136, Apr 07 1998 Pfizer Inc Pharmaceutical tablet
D434846, Jul 07 1999 Merck Sharp & Dohme Corp Tablet
D459798, Mar 26 2001 AVENTIS PHARMA S A Pill tablet
D515202, Jul 19 2004 Merck Sharp & Dohme Corp Tablet
D564086, May 30 2005 Takeda Nycomed AS Tablet
D636070, Feb 26 2010 AstraZeneca AB Tablet
D671636, Apr 23 2010 DAIICHI SANKYO COMPANY, LIMITED Pharmaceutical tablet
D685460, Aug 27 2009 AstraZeneca AB Tablet
D735315, Jun 25 2012 Amgen Inc Pharmaceutical tablet
D754841, Feb 03 2012 JOHNSON & JOHNSON CONSUMER INC Oral dosage form
D755949, Jul 30 2013 RB HEALTH US LLC Tablet
D773641, Sep 15 2009 JOHNSON & JOHNSON CONSUMER INC Oral dosage form
D787042, Apr 28 2015 Celgene Corporation Pharmaceutical tablet
D813372, Feb 22 2017 Celgene Corporation Pharmaceutical tablet
D835257, Feb 22 2017 Celgene Corporation Pharmaceutical tablet
D835258, Feb 22 2017 Celgene Corporation Pharmaceutical tablet
////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Jan 20 2017Société des Produits Nestlé S.A.(assignment on the face of the patent)
Feb 14 2017HASSAN, DANIELPHYSICIAN S SEAL, LLCASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0417300337 pdf
Feb 14 2017HASSAN, FREDPHYSICIAN S SEAL, LLCASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0417300337 pdf
Sep 01 2020PHYSICIAN S SEAL, LLCSOCIÉTÉ DES PRODUITS NESTLÉ S A ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0545160449 pdf
n/a
Date Maintenance Fee Events


n/a
Date Maintenance Schedule